loading
前日終値:
$2.04
開ける:
$2.07
24時間の取引高:
11.20M
Relative Volume:
0.88
時価総額:
$794.76M
収益:
$32.77M
当期純損益:
$-440.22M
株価収益率:
-1.1856
EPS:
-1.67
ネットキャッシュフロー:
$-400.48M
1週間 パフォーマンス:
-11.61%
1か月 パフォーマンス:
+3.66%
6か月 パフォーマンス:
-73.17%
1年 パフォーマンス:
-75.16%
1日の値動き範囲:
Value
$1.97
$2.088
1週間の範囲:
Value
$1.95
$2.22
52週間の値動き範囲:
Value
$1.6385
$12.51

Iovance Biotherapeutics Inc Stock (IOVA) Company Profile

Name
名前
Iovance Biotherapeutics Inc
Name
セクター
Healthcare (1174)
Name
電話
(650) 260-7120
Name
住所
825 INDUSTRIAL ROAD, SAN CARLOS
Name
職員
838
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
IOVA's Discussions on Twitter

IOVA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IOVA
Iovance Biotherapeutics Inc
1.98 794.76M 32.77M -440.22M -400.48M -1.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
440.87 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
509.72 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
309.70 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.15 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
247.08 28.51B 3.81B -644.79M -669.77M -6.24

Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-16 ダウングレード UBS Buy → Neutral
2025-05-12 ダウングレード Truist Buy → Hold
2025-05-09 ダウングレード Citizens JMP Mkt Outperform → Mkt Perform
2024-10-24 開始されました UBS Buy
2024-07-29 ダウングレード Piper Sandler Overweight → Neutral
2023-11-20 開始されました Goldman Buy
2023-09-18 繰り返されました Barclays Overweight
2023-05-30 アップグレード Wells Fargo Equal Weight → Overweight
2023-03-27 再開されました Wells Fargo Equal Weight
2023-01-27 アップグレード Piper Sandler Neutral → Overweight
2022-12-09 ダウングレード Goldman Buy → Neutral
2022-10-31 開始されました Guggenheim Neutral
2022-08-18 再開されました Wells Fargo Equal Weight
2022-01-28 アップグレード Stifel Hold → Buy
2021-12-07 再開されました Cowen Outperform
2021-06-10 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2021-05-20 ダウングレード Piper Sandler Overweight → Neutral
2021-05-19 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2021-05-19 ダウングレード Stifel Buy → Hold
2021-05-03 開始されました Truist Buy
2021-04-16 開始されました Goldman Buy
2021-03-08 アップグレード H.C. Wainwright Neutral → Buy
2020-12-15 ダウングレード H.C. Wainwright Buy → Neutral
2020-10-06 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-22 開始されました Mizuho Buy
2020-03-04 開始されました Barclays Overweight
2020-02-26 繰り返されました H.C. Wainwright Buy
2020-02-26 繰り返されました Oppenheimer Outperform
2019-12-18 開始されました JMP Securities Mkt Outperform
2019-10-01 開始されました Stifel Buy
2019-04-29 開始されました Piper Jaffray Overweight
2019-02-28 繰り返されました Chardan Capital Markets Buy
2019-02-07 開始されました Robert W. Baird Outperform
2018-12-31 再開されました B. Riley FBR Buy
2018-07-06 繰り返されました Chardan Capital Markets Buy
2018-04-10 アップグレード B. Riley FBR, Inc. Neutral → Buy
2018-03-13 繰り返されました B. Riley FBR, Inc. Neutral
2018-02-23 ダウングレード B. Riley FBR, Inc. Buy → Neutral
2018-01-25 繰り返されました H.C. Wainwright Buy
2017-11-01 繰り返されました B. Riley FBR, Inc. Buy
すべてを表示

Iovance Biotherapeutics Inc (IOVA) 最新ニュース

pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesIOVA - FinancialContent

Jun 18, 2025
pulisher
Jun 18, 2025

The Gross Law Firm Notifies Shareholders of Iovance Biotherapeutics, Inc. (IOVA) of a Class ... - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - FinancialContent

Jun 18, 2025
pulisher
Jun 18, 2025

Wealth Enhancement Advisory Services LLC Lowers Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks And Legal PressureHagens Berman - ACCESS Newswire

Jun 18, 2025
pulisher
Jun 17, 2025

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK - Bluefield Daily Telegraph

Jun 17, 2025
pulisher
Jun 17, 2025

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Iovance Biotherapeutics CFO Jean-Marc Bellemin to Depart - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

ROSEN, A LEADING LAW FIRM, Encourages Iovance - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph

Jun 17, 2025
pulisher
Jun 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc.IOVA - PR Newswire

Jun 17, 2025
pulisher
Jun 16, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - PR Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Contact Levi & Korsinsky Before July 14, 2025 to Join Class Action - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) should contact The Gross Law Firm about pending Class ActionIOVA - PR Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Shareholders of Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights Before July 14, 2025 – Contact Levi & Korsinsky - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 15, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance ... - Eagle-Tribune

Jun 15, 2025
pulisher
Jun 15, 2025

Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire

Jun 15, 2025
pulisher
Jun 15, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance Biotherapeutics, Inc.(IOVA) Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 15, 2025

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jun 15, 2025
pulisher
Jun 14, 2025

Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Shareholders of Class Action Lawsuit and July 14, 2025 Deadline - ACCESS Newswire

Jun 14, 2025
pulisher
Jun 14, 2025

Iovance Biotherapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationIOVA - The Victoria Advocate

Jun 14, 2025
pulisher
Jun 14, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph

Jun 14, 2025
pulisher
Jun 14, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance - GlobeNewswire

Jun 14, 2025
pulisher
Jun 14, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA - TradingView

Jun 14, 2025
pulisher
Jun 14, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - StreetInsider

Jun 14, 2025
pulisher
Jun 14, 2025

Iovance: Amtagvi's Rocky Launch And Mounting Concerns Lead To A 'Sell' Rating - Seeking Alpha

Jun 14, 2025
pulisher
Jun 14, 2025

IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA) - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

iovance cfo resigns to pursue new opportunities By Investing.com - Investing.com India

Jun 13, 2025
pulisher
Jun 13, 2025

iovance cfo resigns to pursue new opportunities - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

Iovance Biotherapeutics IncJean-Marc Bellemin To Resign As CFO - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Iovance Biotherapeutics’ SWOT analysis: TIL therapy stock faces challenges amid promise - Investing.com India

Jun 13, 2025
pulisher
Jun 13, 2025

Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA)Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire

Jun 13, 2025
pulisher
Jun 13, 2025

Shareholders of Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jun 13, 2025
pulisher
Jun 13, 2025

Investors who lost money on Iovance Biotherapeutics, Inc. (IOVA) should contact Levi & ... - Bluefield Daily Telegraph

Jun 13, 2025
pulisher
Jun 13, 2025

Investors who lost money on Iovance Biotherapeutics, Inc. - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

IOVA CLASS ACTION: Invest in Iovance Biotherapeutics, Inc.? - GlobeNewswire

Jun 13, 2025
pulisher
Jun 12, 2025

Levi & Korsinsky Urges Iovance Biotherapeutics, Inc. (IOVA) Shareholders to Act Before Lead Plaintiff Deadline July 14, 2025 - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - GlobeNewswire

Jun 12, 2025
pulisher
Jun 12, 2025

IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jun 12, 2025
pulisher
Jun 12, 2025

Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor LawsuitHagens Berman - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

Iovance Biotherapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross ... - Bluefield Daily Telegraph

Jun 12, 2025
pulisher
Jun 12, 2025

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - The Victoria Advocate

Jun 12, 2025
pulisher
Jun 12, 2025

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER - GlobeNewswire

Jun 12, 2025

Iovance Biotherapeutics Inc (IOVA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Iovance Biotherapeutics Inc (IOVA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Puri Raj K.
Chief Regulatory Officer
Jun 02 '25
Option Exercise
0.00
5,469
0
212,321
Vogt Frederick G
Interim CEO & General Counsel
Jun 02 '25
Option Exercise
0.00
52,085
0
426,731
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
Jun 02 '25
Option Exercise
0.00
12,695
0
105,608
BILINSKY IGOR
Chief Operating Officer
Jun 02 '25
Option Exercise
0.00
12,305
0
99,883
Bellemin Jean-Marc
Chief Financial Officer
Jun 02 '25
Option Exercise
0.00
8,789
0
64,993
Puri Raj K.
Chief Regulatory Officer
May 23 '25
Buy
1.74
5,600
9,743
206,852
Vogt Frederick G
Interim CEO & General Counsel
May 14 '25
Buy
1.69
25,000
42,250
374,646
Puri Raj K.
Chief Regulatory Officer
Mar 14 '25
Option Exercise
0.00
8,334
0
203,761
Bellemin Jean-Marc
Chief Financial Officer
Mar 03 '25
Option Exercise
0.00
58,590
0
87,938
BILINSKY IGOR
Chief Operating Officer
Mar 03 '25
Option Exercise
0.00
62,106
0
120,880
$21.16
price down icon 1.86%
$34.86
price down icon 0.14%
$20.56
price up icon 1.98%
$102.68
price up icon 3.24%
$106.53
price up icon 2.04%
biotechnology ONC
$247.08
price down icon 2.25%
大文字化:     |  ボリューム (24 時間):